Are Synthetic Cannabinoids (K2 / Spice) legal in United Kingdom?

Legal status

Synthetic cannabinoids is a label for many unrelated laboratory compounds sold as spice or similar, so the answer is given for the constituents: those within the generic definitions are Class B. Part II of Schedule 2 to the Misuse of Drugs Act 1971 controls them by structure at paragraph 1(c), which lists the naphthoylindole, naphthoylpyrrole, naphthylmethylindene, phenylacetylindole, cyclohexylphenol, benzoylindole, adamantoylindole and tetramethylcyclopropyl families, a paragraph substituted in its present form on 26 February 2013 by S.I. 2013/239, and at paragraph 1(ca), inserted on 14 December 2016 by the Misuse of Drugs Act 1971 (Amendment) Order 2016, S.I. 2016/1109, which reaches any compound «structurally related to 1-pentyl-3-(1-naphthoyl)indole (JWH-018), in that the four sub-structures, that is to say the indole ring, the pentyl substituent, the methanone linking group and the naphthyl ring, are linked together in a similar manner,» within the listed modifications, which take in the indazole carboxamide compounds of the third generation. A named member is «Cumyl-PeGaClone.»; the same paragraph also names the cannabinoid medicine «Nabilone.», which is not a spice constituent. Section 2(1)(b) provides that «the expressions “Class A drug”, “Class B drug” and “Class C drug” mean any of the substances and products for the time being specified respectively in Part I, Part II and Part III of that Schedule». A product whose compound sits outside those definitions is not a controlled drug and falls to the Psychoactive Substances Act 2016, so the highest exposure is the Class B band. Schedule 2 was read as in force on 2 October 2026 in the legislation.gov.uk revised text, which records no known outstanding effects and incorporates S.I. 2024/1361, in force 15 January 2025; Schedule 2 moves by Order in Council under section 2(2), so this does not rule out a later amendment.

Consequences if caught

Capital exposure: none. No provision of the Misuse of Drugs Act 1971, of the Customs and Excise Management Act 1979 or of the Psychoactive Substances Act 2016 provides a death sentence; the highest punishment in Schedule 4 to the 1971 Act is imprisonment for life. For a product whose compound is outside the generic text, the 2016 Act applies instead, with supply, production and import punishable by up to 7 years and no possession offence outside custodial institutions. This row is Class B, so the Class B drug involved column of Schedule 4 to the 1971 Act governs. Possession, section 5(2), carries on indictment «5 years or a fine, or both.» Tried summarily, Class B possession carries «3 months or £2,500, or both.» Possession with intent to supply, section 5(3), supplying or offering to supply, section 4(3), and production, section 4(2), each carry on indictment «14 years or a fine, or both.» Part I of Schedule 2, paragraph 6, adds to Class A «Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.» As the text reads, a preparation of this row designed for administration by injection is therefore a Class A drug, and the Class A column applies to it: «7 years or a fine, or both.» for possession and «Life or a fine, or both.» for supply, production and possession with intent, on indictment. This cell makes no claim about which products are so designed. Sale has no offence of its own: selling is supplying under section 4(3), and trafficking is not a separate offence in the Act, being concerned in another person's supply falling under section 4(3)(b) and (c). Importation and exportation are prohibited by section 3(1) and prosecuted as customs offences under sections 50(3), 68(2) and 170(2) of the Customs and Excise Management Act 1979, which Schedule 1 to that Act punishes for this class «to a penalty of any amount, or to imprisonment for a term not exceeding 14 years, or to both». Cultivation falls under production, because section 37(1) defines producing as «producing it by manufacture, cultivation or any other method». Use is not itself an offence: the Act reaches the user through possession, and its only offence of use is smoking or otherwise using prepared opium under section 9. An occupier who knowingly permits production or supply on premises commits the section 8 offence, also 14 years on indictment. The Act sets no quantity threshold and no statutory presumption of intent to supply; on indictment the fine has no stated maximum and runs with imprisonment or alone, because every band reads «or a fine, or both». No administrative disposal attaches by statute: the penalty notice table in section 1 of the Criminal Justice and Police Act 2001, which applies in England and Wales, lists possession only of cannabis, cannabinol and its derivatives, and khat. Section 28 gives a defence of lack of knowledge; under section 28(3) a belief that it was a different controlled drug is no defence unless, had it been that drug, no offence would have been committed. The Psychoactive Substances Act 2016 does not reach it: section 2(1) of that Act confines a psychoactive substance to one that «is not an exempted substance (see section 3).» and Schedule 1 exempts «Controlled drugs (within the meaning of the Misuse of Drugs Act 1971).» The 1971 Act is therefore read first and governs alone.

If prescribed or medical

In England, Wales and Scotland the Misuse of Drugs Regulations 2001 place it in Schedule 1, under its paragraphs 1(h) to 1(ld), which repeat the generic definitions. The patient possession authority in regulation 10(2) reaches only «a person may have in his possession any drug specified in Schedule 2, 3 or Part I of Schedule 4 for administration for medical, dental or veterinary purposes in accordance with the directions of a practitioner», so a Schedule 1 drug has no prescription route; apart from the regulation 6 authorities for police, customs officers, carriers and forensic laboratories acting in their duties, production, supply and possession are lawful only under a Home Office licence under regulation 5. Nabilone, a cannabinoid medicine, is in Schedule 2 and is prescribable; the generic synthetic cannabinoids are not. On Northern Ireland the sources point two ways, and both are quoted. legislation.gov.uk tags every provision of the 2001 Regulations with the extent E+W+S+N.I. 45 such tags in its XML, while the Regulations themselves carry no extent clause; against that tag, their amending Regulations of 2023 and 2024 each state «These Regulations extend to England and Wales and Scotland.», and the 2026 temporary class drug order applies the two codes separately, saying «The Misuse of Drugs Regulations 2001 apply to the substances and products listed in the Schedule to this Order as if those substances and products were specified in Schedule 1 to those Regulations.» and «The Misuse of Drugs Regulations (Northern Ireland) 2002 apply to the substances and products listed in the Schedule to this Order as if those substances and products were specified in Schedule 1 to those Regulations.» Northern Ireland has its own Misuse of Drugs Regulations (Northern Ireland) 2002, S.R. 2002 No. 1. The legislation.gov.uk text of those Regulations states «There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Misuse of Drugs Regulations (Northern Ireland) 2002.», so the Northern Ireland schedule for this row is not given here.

Documentation

The Home Office page Take medicine in or out of the UK, read at https://www.gov.uk/travelling-controlled-drugs on 2 October 2026, states «You cannot bring schedule 1 drugs into the UK without a licence. Licences for schedule 1 drugs are limited to research or other special purposes.» and «You cannot use a Schengen Certificate to bring schedule 1 drugs into the UK.» No prescription, letter or certificate makes carrying it lawful.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Kingdom’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.